Bahri, Meriem
Kailayangiri, Sareetha
Vermeulen, Sarah
Galopin, Natacha
Rossig, Claudia
Paris, François
Fougeray, Sophie
Birklé, Stéphane http://orcid.org/0000-0001-8217-778X
Funding for this research was provided by:
Ligue contre le Cancer
Fondation BMS pour la recherche en immuno-oncologie
Institut National du Cancer
Fondation de l’Université de Nantes
Article History
Received: 10 September 2020
Accepted: 12 May 2021
First Online: 22 May 2021
Declarations
:
: MB, SV, SF, and SB are inventors of a granted patent covering the therapeutic uses of monoclonal antibodies targeting <i>O</i>-acetyl G<sub>D2</sub> gangliosides.